Research compounds Animal study + human observations Metabolic health
Also discussed as: MOTs-C
What it is and how it works
MOTS-c is a mitochondrial-encoded peptide studied in metabolic stress and muscle biology. The cited work includes mouse intervention experiments and observations of endogenous peptide changes during exercise in people. Those are distinct kinds of evidence.
Source for the mechanism context →A closer look at the cited evidence
Animal study + human observations
This label describes the selected source below. It is not a complete ranking of the literature, a safety score, or an approval status.
- Study or assessment
- Reynolds et al., 2021 — MOTS-c, exercise, and muscle homeostasis
- Design
- Animal interventions and laboratory work, with an exercise-related human observation component.
- Who or what was studied
- Mice and cell models; human observations concerned naturally occurring MOTS-c during exercise.
- What was observed
- The work reported performance-related effects in mice and exercise-associated endogenous changes in people.
- Limits of interpretation
- Observing a peptide in people is not a clinical trial of administering it. These results do not establish a human injectable performance or longevity treatment.
What the evidence means
Metabolism-related research does not establish a safe exercise substitute or a weight-loss treatment.
Approval and regulatory context
Not an FDA-approved metabolic or longevity medicine.
Safety and uncertainty
Human drug exposure data are lacking.
What remains uncertain
Evidence would need to distinguish the normal physiology of a peptide from the effects of an administered product. Mouse performance results do not answer questions about long-term human outcomes or safety.
These summaries are introductory and are not a complete account of the literature, adverse effects, contraindications, or interactions. Absence of a listed risk does not mean absence of risk. Different compounds, formulations, and routes cannot be treated as interchangeable.
Sources behind this overview
- FDA: peptide compounding safety concerns
- Reynolds et al., 2021 — MOTS-c, exercise, and muscle homeostasis
Read the source in its full context. Source links support the overview; they do not imply endorsement of this library by the source organization.